A carregar...

The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

BACKGROUND: Metabolomic processes have been identified as being strongly linked to the development of Alzheimer's disease (AD). Thus, lipid metabolites appear to be highly useful as diagnostic substrates for the diagnosis of AD and mild cognitive impairment (MCI) in plasma. METHODS: We analyzed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Klavins, Kristaps, Koal, Therese, Dallmann, Guido, Marksteiner, Josef, Kemmler, Georg, Humpel, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700585/
https://ncbi.nlm.nih.gov/pubmed/26744734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.05.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!